![]() |
![]() |
![]() |
||
Vice-Chair |
Chair |
Contact Us |
||
Jean-Baptiste Woillard Limoges, France |
Brenda de Winter Rotterdam, Netherlands |
Scientific Committee Pharmacometrics Committee |
Pharmacometrics (PM) has become progressively a key science in the drug development process and increasingly gaining importance in clinical study design and patient care, e.g. to inform dosing decisions within the framework of thereapeutic drug monitoring. It involves the development of (PB)PK or PK/PD or PK/PD/PG models that provide knowledge about the behaviour of a drug and how it can be optimally used. We believe pharmacometrics can help to describe or predict drug concentrations, their relationship with drug effects and clinical impacts. The application of PM models, e.g. using software tools, can also be very helpful to render personalized dose adjustments based on a patient’s individual parameters available in the clinical setting.
2021 | The committee will organize the pre-congress symposium in the IATDMCT 2021 congress in Rome. This meeting is targeted on people not involved in PK/PD modelling at this moment. |
To achieve more efficient use of PK/PD data we will collaborate with other committees, and organize joint symposia for upcoming conferences. | |
Roundtable in Rome: the use of machine learning approaches in clinical pharmacology. | |
2019 | Educational tools we are working on:
|
2021 | Compass submissions:
|
2020 | Compass submissions:
|
2019 | Compass submissions:
|